Impact of Peripheral Vascular Stiffness Assessment on Risk Prediction in Patients With Myocardial Infarction

Launched by UNIVERSITY HOSPITAL, LILLE · Aug 14, 2019

Keywords

ClinConnect Summary

The RIGID-MI clinical trial is studying how measuring the stiffness of blood vessels can help predict risks for patients who have recently had a heart attack, known as myocardial infarction. The goal is to understand which factors—like blood tests and imaging results—are linked to future heart problems, particularly heart failure. Researchers will be enrolling patients who have experienced a heart attack within 48 hours of their symptoms, to see how their blood vessels and overall health change after one month.

To be eligible for this study, participants need to sign a consent form and have a national health insurance number in France. The trial is open to all adults aged 65 and older who are experiencing a heart attack, but those with specific conditions like type 2 heart attacks or those who are pregnant cannot participate. If you join this study, you can expect to undergo various tests and evaluations to help researchers learn more about heart health after a heart attack. Your participation could contribute to better understanding and treatment of heart conditions in the future!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed informed consent
• • Affiliated to national health insurance (French social security number)
• • Presenting with MI within 48 hours of symptom onset
• Exclusion Criteria:
• • Patient under curatorship
• • Type 2 MI
• • Presenting with MI after 48 hours of symptom onset
• • Pregnancy or lactating
• • Refuse to participate
• • No national health insurance (No French social security number)